 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
6-16-2022
Insider Buy |
Biomedical Inc United
>10% Owner |
$1.99
CAGR »
|
$199,290.00
100,000 shares |
6-16-2022
Insider Buy |
Mei Mei Hu
See Remarks |
$1.99
CAGR »
|
$199,290.00
100,000 shares |
6-9-2022
Insider Buy |
Lou Reese
Executive Chairman |
$2.83
CAGR »
|
$59,386.48
20,978 shares |
6-9-2022
Insider Buy |
Mei Mei Hu
See Remarks |
$2.83
CAGR »
|
$59,386.48
20,978 shares |
6-9-2022
Insider Buy |
Biomedical Inc United
>10% Owner |
$2.83
CAGR »
|
$59,386.48
20,978 shares |
4-27-2022
Insider Buy |
Mei Mei Hu
See Remarks |
$3.48
CAGR »
|
$79,689.24
22,912 shares |
4-27-2022
Insider Buy |
Lou Reese
Executive Chairman |
$3.48
CAGR »
|
$79,689.24
22,912 shares |
4-27-2022
Insider Buy |
Biomedical Inc United
>10% Owner |
$3.48
CAGR »
|
$79,689.24
22,912 shares |
4-25-2022
Insider Buy |
Mei Mei Hu
See Remarks |
$3.37
CAGR »
|
$27,072.79
8,038 shares |
4-25-2022
Insider Buy |
Biomedical Inc United
>10% Owner |
$3.37
CAGR »
|
$27,072.79
8,038 shares |
4-25-2022
Insider Buy |
Lou Reese
Executive Chairman |
$3.37
CAGR »
|
$27,072.79
8,038 shares |
12-31-2021
Insider Buy |
James Chui
Director |
$5.48
CAGR »
|
$32,880.00
6,000 shares |
12-10-2021
Insider Buy |
James Chui
Director |
$7.89
CAGR »
|
$63,120.00
8,000 shares |
11-15-2021
Insider Buy |
Ulo Palm
Chief Medical Officer |
$13.00
CAGR »
|
$5,850.00
450 shares |
11-15-2021
Insider Buy |
Lou Reese
Executive Chairman |
$13.82
CAGR »
|
$241,920.00
17,500 shares |
11-15-2021
Insider Buy |
Mei Mei Hu
See Remarks |
$13.82
CAGR »
|
$241,920.00
17,500 shares |
Also See: Institutional Holders of VAXX
Also See: SEC filings
Below we present the annualized performance delivered by VAXX stock since 6-16-2022 (the date of the most recent
insider purchase). The performance of the investment from the time VAXX insider buying occurred is the ultimate
test of whether insiders were right about VAXX being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/17/2022 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$2.08 |
|
| End price/share: |
$0.12 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-94.38% |
|
| Average Annual Total Return: |
-78.71% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$562.63 |
|
| Years: |
1.86 |
|
VAXX Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent VAXX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding VAXX
|
|
Free VAXX Email Alerts:
